HEMOCLAR Price

Overview

Welcome to Dwaey, specifically on HEMOCLAR Cream page.
This medicine contains an important and useful components, as it consists of Pentosan polysulphate.
HEMOCLAR is available in the market in concentration 5mg/g and in the form of Cream.

SANOFI-CLIN MIDY-LABAZ is the producer of HEMOCLAR and it is imported from FRANCE, The most popular alternatives of HEMOCLAR are listed downward .

Mode Of Action

Pentosan polysulfate sodium is a heparinoid with anticoagulant and fibrinolytic properties; it may also have hypolipidaemic and anti-inflammatory effects. It is used in thromboembolic disorders, although its anticoagulant effect is less than that of heparin. It is also used in the management of interstitial cystitis and has been tried in a number of other conditions, including variant Creutzfeldt-Jakob disease.

Indication

• Interstitial cystitis
• Nocturia
• Painful bladder syndrome
• Dyspareunia

Precaution

Patients with spleen disorders, hepatic or renal impairment. Monitor platelet counts during treatment. To discontinue treatment if thrombocytopenia occurs. Caution when used in patients with haemorrhagic blood disorders, thrombocytopenia, peptic ulcer disease, cerebrovascular disorders, bacterial endocarditis, severe hypertension or oesophageal varices. Recent surgery at sites where haemorrhage would be an especial risk. Safety not established in children <16 yr. Patients should be monitored every 3 mth; risks and benefits after 6 mth of treatment not known. Pregnancy; lactation. Lactation: not known if excreted in breast milk, use caution

Side Effects

• 1-10% Alopecia (4%)
• Diarrhea (4%)
• Nausea (4%)
• Headache (3%)
• Abdominal pain (2%)
• Indigestion (2%)

Contra indication

Patients who are haemorrhaging. Serious renal or hepatic impairment. Not to be given via IM inj.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.